Palogic Value Management L.P. Buys New Stake in Amgen Inc.

Palogic Value Management L.P., an institutional investor, recently acquired a new stake in Amgen Inc. (NASDAQ:AMGN), purchasing approximately 7,793 shares valued at $2,822,000 during the second quarter. This purchase represents about 0.9% of Palogic's portfolio and makes AMGN its 23rd largest holding.

Additionally, other large investors have also increased their stakes in Amgen. For instance, Anfield Capital Management LLC raised its holdings by a significant 1,000.0% during the fourth quarter, while Dogwood Wealth Management LLC boosted its stake by 275.0%. Tower View Wealth Management LLC grew its position in AMGN by 331.6%, and Manning & Napier Advisors LLC increased its holding by 49.2%.

On the other hand, insiders have been selling shares of Amgen. SVP Rachna Khosla sold 1,252 shares on August 13th at an average price of $416.43, while SVP Nancy A. Grygiel sold 2,970 shares on August 6th at an average price of $402.16.

Amgen has a market capitalization of $238.06 billion and a P/E ratio of 27.37. The company's revenue for the quarter was up 9.5% compared to the same period last year, and it has set its FY 2026 guidance at 22.300-23.500 EPS.